Arthritis Clinical Trials

Inclusion Criteria:

• Indications consistent with the FDA approved Indications For Use: Index, long, ring, or small finger metacarpophalangeal (MCP) joints that exhibit symptoms of pain, limited motion, or inadequate bony alignment (i.e., subluxation/dislocation) secondary to articular destruction or degenerative disease related to rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, or post-traumatic arthritis where soft tissue reconstruction can provide adequate stabilization;

• Willing to participate in the study;
• Signed an Informed Consent Form
• The means and ability to return for all required study visits; and
• Are not transient.

Exclusion Criteria:

Patients who have any of the following contraindications will be excluded from the study:

• Inadequate bone stock at the implantation site;
• Active infection in the MCP joint;
• Nonfunctioning and irreparable MCP musculotendinous system;
• Physical interference with or by other prostheses during implantation or use;
• Procedures requiring modification of the prosthesis; or
• Skin, bone, circulatory and/or neurological deficiency at the implantation site.